Full marks for the S-level! Shanghai Xinnuo Biotech has passed the international authoritative organization UCLA's interlaboratory quality evaluation.

Recently, the Immuno-Genetic Center of the University of California, Los Angeles (UCLA) announced the results of the inter-room quality evaluation for 2024. The HLA high-resolution gene typing, MICA gene high-resolution typing, HLA antibody testing, and KIR gene typing submitted by Shanghai SinoGenomed received a perfect score of S, proving that Shanghai SinoGenomed has good traceability of results and strict quality management, and its test results are internationally recognized. This perfect score in the UCLA international inter-room quality evaluation fully demonstrates that Shanghai SinoGenomed has received international recognition in the field of hematopoietic stem cell transplantation-related testing technologies. Shanghai SinoGenomed carries out multiple transplant-related testing projects around the entire process of transplantation diagnosis and treatment, providing more comprehensive services for transplant patients and helping clinical doctors to provide disease management and risk control throughout the life cycle of transplant patients.